Gabapentin, an adjuvant treatment for neuropathic pain in a cancer hospital [2]

Journal of Pain and Symptom Management

Volumn 20, Issue 2, 2000, Pages 82-86

  Chandler, Anne ^a   Williams, J E ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CODYDRAMOL; DICLOFENAC; DOSULEPIN; GABAPENTIN; MORPHINE; NAPROXEN; OPIATE; PARACETAMOL; STEROID; TRAMADOL; VALPROIC ACID;

ANALGESIC ACTIVITY; CANCER PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; HUMAN; LETTER; NAUSEA; NEUROPATHY; TREATMENT OUTCOME; VERTIGO;

ACETIC ACIDS; AMINES; ANALGESICS; CANCER CARE FACILITIES; CYCLOHEXANECARBOXYLIC ACIDS; GAMMA-AMINOBUTYRIC ACID; HUMANS; NEOPLASMS; PAIN;

EID: 0033832357     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(00)00166-4     Document Type: Letter

References (2)

1. A Caraceni E Zecca C Martini F DeConno Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain J Pain Symptom Manage 17 1999 441 445
2. McQuay H, Moore A. Anticonvulsant drugs. Antidepressants in neuropathic pain. In: An Evidence Based Resource for Pain Relief. Oxford: Oxford University Press, 1998.